Financial results - ENZYMES & DERIVATES SA

Financial Summary - Enzymes & Derivates Sa
Unique identification code: 6192045
Registration number: J1994001542278
Nace: 4619
Sales - Ron
5.115.149
Net Profit - Ron
94.469
Employees
12
Open Account
Company Enzymes & Derivates Sa with Fiscal Code 6192045 recorded a turnover of 2025 of 5.115.149, with a net profit of 94.469 and having an average number of employees of 12. The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Enzymes & Derivates Sa

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Sales - EUR 3.655.793 4.019.902 3.839.788 3.543.122 3.572.335 3.826.477 4.382.116 4.960.249 5.401.424 5.115.149
Total Income - EUR 3.686.340 4.050.839 3.858.702 3.603.333 3.595.281 3.864.756 4.408.272 4.995.096 5.432.137 5.146.319
Total Expenses - EUR 3.606.945 3.960.392 3.728.779 3.519.207 3.456.636 3.653.767 4.220.850 4.916.930 5.332.110 5.026.917
Gross Profit/Loss - EUR 79.395 90.447 129.924 84.126 138.645 210.990 187.422 78.166 100.028 119.402
Net Profit/Loss - EUR 57.747 65.263 102.360 61.400 113.895 172.051 153.845 55.623 73.732 94.469
Employees 21 21 21 17 14 14 12 14 13 12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -4.0%, from 5.401.424 euro in the year 2024, to 5.115.149 euro in 2025. The Net Profit increased by 21.720 euro, from 73.732 euro in 2024, to 94.469 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Enzymes & Derivates Sa

Rating financiar

Financial Rating -
ENZYMES & DERIVATES SA

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Enzymes & Derivates Sa

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Enzymes & Derivates Sa

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Enzymes & Derivates Sa

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Enzymes & Derivates Sa - CUI 6192045

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Fixed Assets 36.364 33.980 44.469 83.940 101.230 134.936 127.331 125.951 99.361 71.366
Current Assets 1.230.281 1.365.515 1.481.190 1.186.837 1.246.747 1.280.821 1.418.556 1.503.536 1.617.864 1.394.126
Inventories 287.950 260.599 283.559 218.440 288.225 234.480 252.457 262.029 291.120 306.550
Receivables 966.385 1.164.921 1.256.888 1.028.900 997.695 1.036.032 1.159.001 1.193.708 1.454.306 1.158.691
Cash -24.054 -60.005 -59.256 -60.503 -39.173 10.310 7.098 47.800 -127.562 -71.115
Shareholders Funds 704.345 757.782 795.204 615.427 694.810 802.667 780.373 833.629 902.702 824.426
Social Capital 33.402 32.836 64.468 30.345 29.770 29.110 29.200 29.111 28.949 28.563
Debts 562.300 641.713 730.455 655.350 653.166 613.090 765.514 795.858 814.523 641.065
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 5.0415 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.394.126 euro in 2025 which includes Inventories of 306.550 euro, Receivables of 1.158.691 euro and cash availability of -71.115 euro.
The company's Equity was valued at 824.426 euro, while total Liabilities amounted to 641.065 euro. Equity decreased by -66.243 euro, from 902.702 euro in 2024, to 824.426 in 2025.

Risk Reports Prices

Reviews - Enzymes & Derivates Sa

Comments - Enzymes & Derivates Sa

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.